B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: Little association with serum IgG antibody

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2673-2681

  Perrett, Kirsten P ^a,b,c   Jin, Celina ^a,b   Clutterbuck, Elizabeth ^a,b   John, Tessa M ^a,b   Winter, Amy P ^a,b   Kibwana, Elizabeth ^a,b   Yu, Ly Mee ^a   Curtis, Nigel ^c   Pollard, Andrew J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MENINGOCOCCUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR IMMUNITY; CHILD; CROSS PRESENTATION; DRUG CONJUGATION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; MEMORY CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEADY STATE; TREATMENT INDICATION; VACCINATION;

AGE FACTORS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTE SUBSETS; CHILD; CLINICAL TRIALS, PHASE IV AS TOPIC; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP C; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 84865433518     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200451     Document Type: Article

References (50)

1. Nadel, S., and J. S. Kroll. 2007. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol. Rev. 31: 71-83.
2. Booy, R., P. Habibi, S. Nadel, C. de Munter, J. Britto, A. Morrison, and M. Levin; Meningococcal Research Group. 2001. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch. Dis. Child. 85: 386-390.
3. Ramsay, M. E., N. Andrews, E. B. Kaczmarski, and E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357: 195-196.
4. Booy, R., J. Jelfs, H. El Bashir, and M. D. Nissen. 2007. Impact of meningococcal C conjugate vaccine use in Australia. Med. J. Aust. 186: 108-109.
5. Salleras, L., A. Domínguez, and N. Cardeñosa. 2003. Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine. Vaccine 21: 729-733.
6. Maiden, M. C., A. B. Ibarz-Pavón, R. Urwin, S. J. Gray, N. J. Andrews, S. C. Clarke, A. M. Walker, M. R. Evans, J. S. Kroll, K. R. Neal, et al. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197: 737-743.
7. Ramsay, M. E., N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller. 2003. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326: 365-366.
8. Trotter, C. L., N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364: 365-367.
9. Pollard, A. J., K. P. Perrett, and P. C. Beverley. 2009. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat. Rev. Immunol. 9: 213-220.
10. Adams, W. G., K. A. Deaver, S. L. Cochi, B. D. Plikaytis, E. R. Zell, C. V. Broome, and J. D. Wenger. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269: 221-226.
11. Eskola, J., H. Käyhty, A. K. Takala, H. Peltola, P. R. Rönnberg, E. Kela, E. Pekkanen, P. H. McVerry, and P. H. Mäkelä. 1990. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 323: 1381-1387.
12. Eskola, J. 1996. Analysis of Haemophilus influenzae type B conjugate and diphtheria-tetanus-pertussis combination vaccines. J. Infect. Dis. 174(Suppl. 3): S302-S305.
13. McVernon, J., J. MacLennan, A. J. Pollard, P. Oster, M. J. Wakefield, L. Danzig, and E. R. Moxon. 2003. Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years. Pediatr. Infect. Dis. J. 22: 659-661.
14. Auckland, C., S. Gray, R. Borrow, N. Andrews, D. Goldblatt, M. Ramsay, and E. Miller. 2006. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J. Infect. Dis. 194: 1745-1752.
15. McVernon, J., P. D. Johnson, A. J. Pollard, M. P. Slack, and E. R. Moxon. 2003. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch. Dis. Child. 88: 379-383.
16. Snape, M. D., D. F. Kelly, P. Salt, S. Green, C. Snowden, L. Diggle, A. Borkowski, L. M. Yu, E. R. Moxon, and A. J. Pollard. 2006. Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin. Infect. Dis. 43: 1387-1394.
17. Yazdankhah, S. P., and D. A. Caugant. 2004. Neisseria meningitidis: an overview of the carriage state. J. Med. Microbiol. 53: 821-832.
18. Crotty, S., and R. Ahmed. 2004. Immunological memory in humans. Semin. Immunol. 16: 197-203.
19. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
20. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122.
21. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
22. Manz, R. A., S. Arce, G. Cassese, A. E. Hauser, F. Hiepe, and A. Radbruch. 2002. Humoral immunity and long-lived plasma cells. Curr. Opin. Immunol. 14: 517-521.
23. Crotty, S., P. Felgner, H. Davies, J. Glidewell, L. Villarreal, and R. Ahmed. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171: 4969-4973.
24. Lanzavecchia, A., N. Bernasconi, E. Traggiai, C. R. Ruprecht, D. Corti, and F. Sallusto. 2006. Understanding and making use of human memory B cells. Immunol. Rev. 211: 303-309.
25. Perrett, K. P., A. P. Winter, E. Kibwana, C. Jin, T. M. John, L. M. Yu, R. Borrow, N. Curtis, and A. J. Pollard. 2010. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin. Infect. Dis. 50: 1601-1610.
26. Kelly, D. F., M. D. Snape, K. P. Perrett, E. A. Clutterbuck, S. Lewis, G. B. Rohner, M. Jones, L. M. Yu, and A. J. Pollard. 2009. Plasma and memory B-cell kinetics in infants following a primary schedule of CRM-conjugated serogroup C meningococcal polysaccharide vaccine. [Published erratum appears in 2011 Immunology 132: 589.] Immunology 127: 134-143.
27. Nanan, R., D. Heinrich, M. Frosch, and H. W. Kreth. 2001. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory Blymphocytes. Vaccine 20: 498-504.
28. Blanchard Rohner, G., M. D. Snape, D. F. Kelly, T. John, A. Morant, L. M. Yu, A. Borkowski, F. Ceddia, R. Borrow, C. A. Siegrist, and A. J. Pollard. 2008. The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J. Immunol. 180: 2165-2173.
29. Kelly, D. F., M. D. Snape, E. A. Clutterbuck, S. Green, C. Snowden, L. Diggle, L. M. Yu, A. Borkowski, E. R. Moxon, and A. J. Pollard. 2006. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 108: 2642-2647.
30. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
31. Maruyama, M., K. P. Lam, and K. Rajewsky. 2000. Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407: 636-642.
32. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381: 751-758.
33. Pihlgren, M., M. Friedli, C. Tougne, A. F. Rochat, P. H. Lambert, and C. A. Siegrist. 2006. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J. Immunol. 176: 165-172.
34. Pihlgren, M., N. Schallert, C. Tougne, P. Bozzotti, J. Kovarik, A. Fulurija, M. Kosco-Vilbois, P. H. Lambert, and C. A. Siegrist. 2001. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur. J. Immunol. 31: 939-946.
35. Siegrist, C. A., and R. Aspinall. 2009. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9: 185-194.
36. Avci, F. Y., X. Li, M. Tsuji, and D. L. Kasper. 2011. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat. Med. 17: 1602-1609.
37. Kaur, K., S. Chowdhury, N. S. Greenspan, and J. R. Schreiber. 2007. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 110: 2948-2954.
38. Belnoue, E., M. Pihlgren, T. L. McGaha, C. Tougne, A. F. Rochat, C. Bossen, P. Schneider, B. Huard, P. H. Lambert, and C. A. Siegrist. 2008. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111: 2755-2764.
39. Clutterbuck, E. A., P. Salt, S. Oh, A. Marchant, P. Beverley, and A. J. Pollard. 2006. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. Immunology 119: 328-337.
40. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69: 1895-1902.
41. Manz, R. A., A. Thiel, and A. Radbruch. 1997. Lifetime of plasma cells in the bone marrow. Nature 388: 133-134.
42. Traggiai, E., R. Puzone, and A. Lanzavecchia. 2003. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21(Suppl. 2): S35-S37.
43. Klein, U., K. Rajewsky, and R. Küppers. 1998. Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
44. Cassese, G., S. Arce, A. E. Hauser, K. Lehnert, B. Moewes, M. Mostarac, G. Muehlinghaus, M. Szyska, A. Radbruch, and R. A. Manz. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171: 1684-1690.
45. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
46. Dorfman, J. R., P. Bejon, F. M. Ndungu, J. Langhorne, M. M. Kortok, B. S. Lowe, T. W. Mwangi, T. N. Williams, and K. Marsh. 2005. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 191: 1623-1630.
47. Macallan, D. C., D. L. Wallace, Y. Zhang, H. Ghattas, B. Asquith, C. de Lara, A. Worth, G. Panayiotakopoulos, G. E. Griffin, D. F. Tough, and P. C. Beverley. 2005. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105: 3633-3640.
48. Leyendeckers, H., M. Odendahl, A. Löhndorf, J. Irsch, M. Spangfort, S. Miltenyi, N. Hunzelmann, M. Assenmacher, A. Radbruch, and J. Schmitz. 1999. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur. J. Immunol. 29: 1406-1417.
49. Manz, R. A., M. Löhning, G. Cassese, A. Thiel, and A. Radbruch. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10: 1703-1711.
50. Clutterbuck, E. A., R. Lazarus, L. M. Yu, J. Bowman, E. A. Bateman, L. Diggle, B. Angus, T. E. Peto, P. C. Beverley, D. Mant, and A. J. Pollard. 2012. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J. Infect. Dis. 205: 1408-1416.